Molidustat CAS NO.1154028-82-6

molidustat, also known as bay 85-3934, is a novel inhibitor of hypoxia-inducible factor (hif) prolyl hydroxylase (ph) which stimulates erythropoietin (epo) production and the formation of red blood cells. phase i data have shown that inhibition of hif-ph by molidustat results in an increase in endogenous production of epo. molidustat is currently clinical trials at bayer for the treatment of patients suffering from renal anemia due to chronic kidney disease.

tianjin kailiqi biopharma technology co., ltd, is a professional manufacturer specialized in the production and distribution of active pharmaceutical ingredients and intermediates. our company has strong r&d ability and production experience to provide the customers new apis. we specialize in developing innovative processes for the synthesis of a wide range of products. we also undertake custom synthesis and contract manufacturing.if you are interest in,pls contact with me,we also have lab,specifical in some hard synthesis.